120 related articles for article (PubMed ID: 38857596)
1. Retraction Notice to: The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB.
Sun M; Nie FQ; Zang C; Wang Y; Hou J; Wei C; Li W; He X; Lu KH
Mol Ther; 2024 Jun; ():. PubMed ID: 38857596
[No Abstract] [Full Text] [Related]
2. The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB.
Sun M; Nie FQ; Zang C; Wang Y; Hou J; Wei C; Li W; He X; Lu KH
Mol Ther; 2017 Mar; 25(3):739-751. PubMed ID: 28131418
[TBL] [Abstract][Full Text] [Related]
3. The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression.
Ma HW; Xie M; Sun M; Chen TY; Jin RR; Ma TS; Chen QN; Zhang EB; He XZ; De W; Zhang ZH
Oncotarget; 2017 Aug; 8(32):52211-52224. PubMed ID: 28881724
[TBL] [Abstract][Full Text] [Related]
4. DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2.
Lian Y; Yang J; Lian Y; Xiao C; Hu X; Xu H
Cancer Commun (Lond); 2018 Oct; 38(1):64. PubMed ID: 30367681
[TBL] [Abstract][Full Text] [Related]
5. The double homeobox a pseudogene 8 accelerates cell proliferation, migration, and invasion in colon cancer.
Mao S; Mo Z; Wu R; Lai B; Zhou Z; Song Y; Ouyang X; Zhu X
Bioengineered; 2022 Apr; 13(4):8164-8173. PubMed ID: 35287542
[TBL] [Abstract][Full Text] [Related]
6. Functions of lncRNA DUXAP8 in non-small cell lung cancer.
Wu C; Song W; Wang Z; Wang B
Mol Biol Rep; 2022 Mar; 49(3):2531-2542. PubMed ID: 35031926
[TBL] [Abstract][Full Text] [Related]
7. Long Non-coding RNA DUXAP8 Regulates the Cell Proliferation and Invasion of Non-small-cell Lung Cancer.
Yang SJ; Weng JL; Wei B; Du XK
Open Life Sci; 2019 Jan; 14():201-207. PubMed ID: 33817152
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.
Ji X; Tao R; Sun LY; Xu XL; Ling W
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3152-3165. PubMed ID: 32271433
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA DUXAP8 promotes tumorigenesis by regulating IGF1R via miR-9-3p in hepatocellular carcinoma.
Guan Q; Yuan B; Zhang X; Yan T; Li J; Xu W
Exp Ther Med; 2021 Jul; 22(1):755. PubMed ID: 34035852
[TBL] [Abstract][Full Text] [Related]
10. The Pseudogene DUXAP8 Promotes Colorectal Cancer Cell Proliferation, Invasion, and Migration by Inducing Epithelial-Mesenchymal Transition Through Interacting with EZH2 and H3K27me3.
He W; Yu Y; Huang W; Feng G; Li J
Onco Targets Ther; 2020; 13():11059-11070. PubMed ID: 33149618
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of pseudogene DUXAP8 expression in glioma suppresses tumor cell proliferation.
Zhao X; Hao S; Wang M; Xing D; Wang C
Oncol Lett; 2019 Mar; 17(3):3511-3516. PubMed ID: 30867791
[TBL] [Abstract][Full Text] [Related]
12. Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p.
Liu Y; Zhang G; Chen H; Wang H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33269379
[TBL] [Abstract][Full Text] [Related]
13. YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2.
Yang Z; Ding H; Pan Z; Li H; Ding J; Chen Q
Cancer Biol Ther; 2021 Mar; 22(3):216-224. PubMed ID: 33683171
[TBL] [Abstract][Full Text] [Related]
14. LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway.
Lei C; Li S; Fan Y; Hua L; Pan Q; Li Y; Long Z; Yang R
Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 36329030
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
[TBL] [Abstract][Full Text] [Related]
16. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
17. Pseudogene
Zhang H; Chu K; Zheng C; Ren L; Tian R
Front Genet; 2020; 11():666. PubMed ID: 32849765
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA DUXAP8 Acts as an Oncogene in Sinonasal Squamous Cell Carcinoma Through miR-584-5p/FNDC3B Pathway.
Chen X; Li G; Zhong G; Chen J; Feng L; Zhang T; Tang Z
Am J Rhinol Allergy; 2022 Nov; 36(6):708-718. PubMed ID: 35695194
[TBL] [Abstract][Full Text] [Related]
19.
Yue C; Liang C; Li P; Yan L; Zhang D; Xu Y; Wei Z; Wu J
Onco Targets Ther; 2019; 12():11637-11650. PubMed ID: 32021243
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA DUXAP8 Facilitates Cell Viability, Migration, and Glycolysis in Non-Small-Cell Lung Cancer via Regulating HK2 and LDHA by Inhibition of miR-409-3p.
Yin D; Hua L; Wang J; Liu Y; Li X
Onco Targets Ther; 2020; 13():7111-7123. PubMed ID: 32801745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
